LGA
BSX icon

Lebenthal Global Advisors’s Boston Scientific BSX Stock Holding History

Lebenthal Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.2K Buy
800
+600
+300% +$48K 0.01% 190
2025
Q4 		$19.1K Buy
+200
New +$19.6K ﹤0.01% 183

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lebenthal Global Advisors's BSX Position: Q1 2026 in Review

Lebenthal Global Advisors increased its Boston Scientific (BSX) stake by 3.1% in Q1 2026, buying an estimated $53.1K and bringing the position to 21,807 shares worth $1.37M. The position accounts for 0.2% of the portfolio, ranked #79.

Lebenthal Global Advisors first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.02M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Lebenthal Global Advisors held 21,807 shares of Boston Scientific worth $1.37M as of Q1 2026.
  • Lebenthal Global Advisors bought 664 Boston Scientific shares in Q1 2026, an estimated $53.1K.
  • Boston Scientific made up 0.2% of Lebenthal Global Advisors's portfolio in Q1 2026, its #79 holding.
  • Lebenthal Global Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
  • Lebenthal Global Advisors's Boston Scientific position peaked at $2.02M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.